The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
8,499
Sort by:
Global Vitamin E Market 2021 - Industry Statistics
US$ 750.00
Vitamin E is a group of eight fat soluble compounds that include four tocopherols and four tocotrienols. Vitamin E helps maintain healthy skin and eyes, and strengthen the body's natural defence again...
December 2021
66 pages
Global Over the Counter (OTC) Drugs Market, By Product (Cough, Cold & Flu, Vitamins, Mineral, & Supplements (VMS), Analgesics, Gastrointestinal Products, Dermatology Products, Others), By Route of Administration (Oral, Parenteral, Topical, Others), By Dosage Form (Tablets, Capsules, Liquids & Solutions, Cream/Lotion/Ointments, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition, Forecast & Opportunities, 2026
US$ 4,900.00
Global Over the Counter (OTC) drugs market is anticipated to grow at CAGR of 9.86% through 2026 to reach USD274.15 billion by the end of forecast period, 2026. Future growth of the global over the cou...
December 2021
115 pages
United States Generic Drugs Market, By Type (Small Molecule Generics v/s Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Infectious Diseases, Others), By Mode of Drug Delivery (Oral, Topical, Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House v/s Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Region, Competition, Forecast and Opportunity, 2026
US$ 4,400.00
United States generic drugs market was valued USD70.78 billion in 2020 and is forecast to grow at CAGR of 9.43% during the forecast period and may achieve market value of USD126.74 billion by the year...
December 2021
75 pages
Asia Pacific Drug Discovery Market 2020-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity
US$ 2,295.00
Asia Pacific drug discovery market will grow by 10.6% annually with a total addressable market cap of $231.8 billion over 2021-2030 owing the rising demand for specialty medicines, the surge in lifest...
November 2021
120 pages
Asia Pacific Injectable Drugs Market 2020-2030 by Molecule Type (Small, Large), Drug Class (mAbs, Immunoglobulin, Insulin, Vaccines, Cytokines, Peptide Hormone, Blood Factors), Delivery (Pre-filled Syringe, Infusions, Others), Application (Oncology, Infectious Diseases, Autoimmune, Cardiovascular), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce), and Country: Trend Forecast and Growth Opportunity
US$ 2,125.00
Asia Pacific injectable drugs market will grow by 13.0% annually with a total addressable market cap of $2,165.4 billion over 2021-2030 owing to the increasing prevalence of chronic diseases, rising u...
November 2021
109 pages
Europe Drug Discovery Market 2020-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity
US$ 2,295.00
Europe drug discovery market was valued at $14.8 billion in 2020 and will grow by 8.3% annually over 2020-2030 owing the rising demand for specialty medicines, the surge in lifestyle-oriented diseases...
November 2021
123 pages
Europe Injectable Drugs Market 2020-2030 by Molecule Type (Small, Large), Drug Class (mAbs, Immunoglobulin, Insulin, Vaccines, Cytokines, Peptide Hormone, Blood Factors), Delivery (Pre-filled Syringe, Infusions, Others), Application (Oncology, Infectious Diseases, Autoimmune, Cardiovascular), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce), and Country: Trend Forecast and Growth Opportunity
US$ 2,125.00
Europe injectable drugs market was valued at $104.8 billion in 2020 and will grow by 9.7% annually over 2020-2030 owing to the increasing prevalence of chronic diseases, rising use of self-administere...
November 2021
111 pages
Global Drug Discovery Market 2020-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Region: Trend Forecast and Growth Opportunity
US$ 2,720.00
Global drug discovery market will reach $117.6 billion by 2030, growing by 8.6% annually over 2020-2030 driven by the rising demand for specialty medicines, the surge in lifestyle-oriented diseases an...
November 2021
181 pages
Global Injectable Drugs Market 2020-2030 by Molecule Type (Small, Large), Drug Class (mAbs, Immunoglobulin, Insulin, Vaccines, Cytokines, Peptide Hormone, Blood Factors), Delivery (Pre-filled Syringe, Infusions, Others), Application (Oncology, Infectious Diseases, Autoimmune, Cardiovascular), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce), and Region: Trend Forecast and Growth Opportunity
US$ 2,465.00
Global injectable drugs market will reach $1,037.7 billion by 2030, growing by 9.8% annually over 2020-2030 driven by the increasing prevalence of chronic diseases, rising use of self-administered Inj...
November 2021
165 pages
North America Drug Discovery Market 2020-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity
US$ 2,295.00
North America drug discovery market is expected to grow by 7.9% annually in the forecast period and reach $41.44 billion by 2030 driven by the rising demand for specialty medicines, the surge in lifes...
November 2021
117 pages
North America Injectable Drugs Market 2020-2030 by Molecule Type (Small, Large), Drug Class (mAbs, Immunoglobulin, Insulin, Vaccines, Cytokines, Peptide Hormone, Blood Factors), Delivery (Pre-filled Syringe, Infusions, Others), Application (Oncology, Infectious Diseases, Autoimmune, Cardiovascular), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce), and Country: Trend Forecast and Growth Opportunity
US$ 2,125.00
North America injectable drugs market is expected to grow by 8.3% annually in the forecast period and reach $372.9 billion by 2030 driven by the increasing prevalence of chronic diseases, rising use o...
November 2021
102 pages
Bladder Cancer (Oncology) - Drugs in Development, 2021
US$ 2,500.00
Bladder Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer - Drugs In Development, 2021, provides...
November 2021
2564 pages
Gaucher Disease - Drugs in Development, 2021
US$ 2,000.00
Gaucher Disease - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gaucher Disease - Drugs In Development, 2021, provides an overv...
November 2021
143 pages
Hypertension (Cardiovascular) - Drugs in Development, 2021
US$ 2,500.00
Hypertension (Cardiovascular) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypertension - Drugs In Development, 2021, provid...
November 2021
872 pages
Keloids (Dermatology) - Drugs in Development, 2021
US$ 2,000.00
Keloids (Dermatology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Keloids - Drugs In Development, 2021, provides an overvie...
November 2021
51 pages
Macular Edema (Ophthalmology) - Drugs in Development, 2021
US$ 2,000.00
Macular Edema (Ophthalmology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Macular Edema - Drugs In Development, 2021, provi...
November 2021
102 pages
Melanoma (Oncology) - Drugs in Development, 2021
US$ 2,500.00
Melanoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Melanoma - Drugs In Development, 2021, provides an overview...
November 2021
4610 pages
P2X Purinoceptor 3 (P2RX3) - Drugs in Development, 2021
US$ 3,500.00
P2X Purinoceptor 3 (P2RX3) - Drugs in Development, 2021 SUMMARY P2X Purinoceptor 3 (P2RX3) - P2X purinoceptor 3 is a protein encoded by the P2RX3 gene. It belongs to the family of purinoceptors. This...
November 2021
70 pages